The cytotoxic drugs market size is projected to develop significantly during the forecast time period, attributable to growing occurrences of cancer around the world. As per World Health Organization’s (WHO) 2018 report, around 9.6 million deaths were recorded because of disease and around 18.1 million new instances of malignancy were analysed in 2018 around the world.
Besides, growing number of cytotoxic medication endorsements is expected to support the market development. For example, in November 2018, the U.S. FDA endorsed Pfizer’s DAURISMO (glasdegib) in the U.S. for grown-up patients with recently analyzed intense myeloid leukemia for whom serious chemotherapy isn’t an alternative. Other potential factor that donates to cytotoxic drugs market revenue growth is growing therapeutic area of cytotoxic drugs in auto-immune conditions, rheumatoid arthritis, psoriasis, or prevention of transplant refusal because of its immunosuppressive or anti–proliferative effects.
The major restricting growth of the cytotoxic drug market development is adverse results appeared by utilization of cytotoxic medications like queasiness and spewing, extreme looseness of the bowels, and harm to bone marrow. Cytotoxic medications can be harmful to other organ frameworks and lead to conditions like gastrointestinal poisonousness, neurotoxicity renal harmfulness, and cardiovascular harmfulness. For example, as per NHS Lothian Joint Formulary, medications like fluorouracil, doxorubicin, and oral capecitabine may cause serious stomatitis, looseness of the bowels, and coronary fit copying angina. In addition, fundamental enemy of malignancy treatment (SACT) drugs increment the danger of thromboembolic sickness at last controlling the cytotoxic medications market development.
North America is projected to stand firm on a predominant footing in the cytotoxic drug market over the forecast time frame, attributable to expanding mindfulness and accessibility of wide scope of cytotoxic medications around there. As per an investigation distributed in National Center for Biotechnology Information (NCBI) in 2017, the U.S. Food and Drug Administration has supported 61 cytotoxic medications for malignant growth, which help in expanding the endurance paces of disease patients.
Asia Pacific cytotoxic medications market size is expected to observe huge development, inferable from huge patient base and expanding medical care protection plans around there. For example, in 2018, the Government of India dispatched Pradhan Mantri Jan Arogya Yojana (PMJAY) to give health care coverage worth US$ 7,124.54 to more than 100 million families, every year.
The major companies operating in the worldwide cytotoxic drugs market include, Eli Lilly and Company, Sanofi S.A., F. Hoffmann-La Roche Ltd, Pfizer Inc., Celgene Corporation, Amgen Inc., Novartis AG Merck and Co., Johnson and Johnson, and GlaxoSmithKline Plc.
Global Cytotoxic Drugs Market: Taxonomy
The global cytotxic drugs market is segmented on the basis of drug type, application, route of administration, distribution channel, and region.
By Drug Type
Vinca Alkaloids and Etoposide
By Route of Administration
By Distribution Channel
Reasons to Purchase this Report
• Current and future of global Cytotoxic Drugs market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
Global Cytotoxic Drugs Market Research Report
Section 1: Global Cytotoxic Drugs Industry Overview
Section 2: Global Economic Impact on Cytotoxic Drugs Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Cytotoxic Drugs Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027